Search Results
Nov 10, 2025, 14:00 ET CT Manufacturing Company Mitigates Increasing Freight Rates for Moving Military Families
temperatures, shaking or puncturing during transit. TR Sleeve™ -
More news about: Packaging And Crating Technologies
Nov 07, 2025, 03:00 ET RiderNav dévoile le R7M, un écran BMW de 7 pouces avec CarPlay® / Android Auto™ sans fil et Insta360/GoPro/DJI Control
automatiquement et prend en charge le Wonder Wheel. Pas de câblage supplémentaire.Données en temps réel sur les motos d'origine : Tr/min, surveillance de la pression des pneus, angle d'inclinaison, plage, tension, température du liquide de refroidissement.Écran HD 1 200 nits,
More news about: RiderNav
Nov 05, 2025, 01:38 ET CTEK Powers The Unveil Of The Ruffian35: A Modern Masterpiece Born From The Soul Of A 1935 Plymouth
been stroked to 9.0 liters and fortified with forged internals to deliver 803 horsepower and 741 lb-ft of torque. Paired with a Tick Performance 6-speed TR6060 transmission and a Ford 9-inch floater rear axle, the Ruffian Plymouth GT-1 commands both brute strength and finesse—nearly matching the original
More news about: CTEK
Nov 04, 2025, 02:00 ET SKF, çevresel etkiyi azaltabilecek teknolojilerin paylaşılacağı bir platform olan Patent Bay'i hizmete sunuyor
https://www.skf.com/tr/fighting-friction/02 Daha fazla bilgi için lütfen şu iletişim bilgilerini kullanın: Karin
More news about: SKF Group
Nov 03, 2025, 11:58 ET New Study Explores Placental Malperfusion's Impact on Fetal Health and Development in Congenital Heart Disease
outcomes. The work was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (UL1TR001878), National Human Genome Research Institute (R01HG013355) and the National Heart Lung and Blood Institute (T32 HL007915-25). Josowitz et al.
More news about: Children's Hospital of Philadelphia
Oct 29, 2025, 21:00 ET Jenscare released its multi-product portfolio's, including LuX-Valve Plus TRINITY study, JensClip and Ken-Valve, remarkable clinical outcomes at TCT 2025 in the U.S.
embolism. The efficacy indicators show that the tricuspid regurgitation (TR) grade, NYHA classification, and QoL improved significantly at 6 months. 94.4% of the patients show no above moderate TR. 90.9% of them show postoperative NYHA class I/II. KCCQ score increased by around 19 pts
More news about: Jenscare Scientific Co., Ltd.
Oct 29, 2025, 15:28 ET Halloween: com o soundbar LG S95TR, usuário vive o terror como se estivesse dentro do filme
a experiência vai além da tela. O LG Home Theater Soundbar S95TR é a companhia ideal para quem quer sentir cada arrepio como se estivesse dentro do filme. O soundbar premium
More news about: LG Electronics Brasil
Oct 29, 2025, 14:22 ET Copper Mountain Technologies Announces Raspberry Pi Compatibility for Vector Network Analyzers
The software is Initially available for CMT's 1-Port and TR Series VNAs that are most often used in field or embedded S-parameter measurement applications. "We recognize the importance
More news about: Copper Mountain Technologies
Oct 28, 2025, 08:26 ET LG transforma sala de casa em cinema
soundbar S95TR oferece um áudio tridimensional que preenche o ambiente e envolve o espectador em uma bolha sonora. Junto aos 15 canais de áudio e aos potentes
More news about: LG Electronics Brasil
Oct 26, 2025, 15:50 ET Cardiovalve schließt die Rekrutierung für die TARGET-Studie zur CE-Zulassung für den Trikuspidalklappenersatz ab
CE-Kennzeichnung bei den europäischen Aufsichtsbehörden im Laufe dieses Jahres vor. Vorbehaltlich der Zulassung ist die Markteinführung des Cardiovalve TR-Systems in Europa für 2027 vorgesehen. Aufbauend auf diesem Erfolg bereitet Cardiovalve derzeit die Einleitung seiner AHEAD-Studie
More news about: Venus Medtech (Hangzhou) Inc.
Oct 25, 2025, 03:00 ET Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement
preparing to submit its CE Mark application to European regulators later this year. Pending approval, commercial launch of the Cardiovalve TR system in Europe is projected for 2027. Building on this achievement, Cardiovalve is also preparing to initiate its AHEAD
More news about: Venus Medtech (Hangzhou) Inc.
Oct 25, 2025, 03:00 ET Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement
preparing to submit its CE Mark application to European regulators later this year. Pending approval, commercial launch of the Cardiovalve TR system in Europe is projected for 2027. Building on this achievement, Cardiovalve is also preparing to initiate its AHEAD
More news about: Venus Medtech (Hangzhou) Inc.
Oct 25, 2025, 03:00 ET Cardiovalve completa la inscripción al estudio TARGET
ante los organismos reguladores europeos a finales de este año. A la espera de la aprobación, el lanzamiento comercial del sistema Cardiovalve TR en Europa está previsto para 2027. Basándose en este logro, Cardiovalve también
More news about: Venus Medtech (Hangzhou) Inc.
Oct 25, 2025, 03:00 ET Cardiovalve termine le recrutement pour l'étude TARGET en vue de l'enregistrement du marquage CE pour le remplacement de la valve tricuspide
de marquage CE aux régulateurs européens dans le courant de l'année. En attendant l'approbation, le lancement commercial du système Cardiovalve TR en Europe est prévu pour 2027. Sur la base de ces résultats, Cardiovalve se prépare également à lancer son étude AHEAD,
More news about: Venus Medtech (Hangzhou) Inc.
Oct 24, 2025, 14:39 ET Laplace Interventional completes Trans-Jugular US Early Feasibility Study and adds Trans-Femoral approach
Laplace Interventional's device aims to offer an improvement to the quality of life to patients worldwide diagnosed with Tricuspid Regurgitation (TR). Laplace Interventional is developing a prosthetic valve that is delivered through a minimally invasive procedure, either through a vein in neck or groin
More news about: Laplace Interventional, Inc.
Oct 21, 2025, 11:23 ET Ecuador zegt klaar te zijn om tegen de Fusarium-plaag op te treden en de bananenexport gaande te houden
GUAYAQUIL, Ecuador, 21 oktober 2025 /PRNewswire/ -- Fusarium TR4, momenteel de meest gevreesde plaag voor bananenplantages die al grote schade in Latijns-Amerikaanse landen als Colombia, Venezuela en Peru heeft aangericht,
More news about: AEBE
Oct 21, 2025, 11:16 ET Ecuador ist bereit, gegen Fusarium-Plage vorzugehen und Bananenexporte aufrechtzuerhalten
GUAYAQUIL, Ecuador, 21. Oktober 2025 /PRNewswire/ -- Fusarium TR4, die derzeit am meisten gefürchtete Seuche für Bananenplantagen, die bereits in lateinamerikanischen Ländern wie Kolumbien, Venezuela und Peru große
More news about: AEBE
Oct 21, 2025, 03:15 ET Ecuador says it is ready to act against Fusarium plague and keep banana exports flowing
GUAYAQUIL, Ecuador, Oct. 21, 2025 /PRNewswire/ -- Fusarium TR4, the most feared current plague for banana plantations, which has already caused major damage in Latin American countries such as Colombia, Venezuela
More news about: AEBE
Oct 20, 2025, 17:00 ET PMET Resources Delivers Positive CV5 Lithium-Only Feasibility Study for its Large-Scale Shaakichiuwaanaan Project
Mine Waste Materials & Modelling of Waste Rock Stockpiles for the Shaakichiuwaanaan Project (CV5 Pegmatite): Feasibility Study Update. Ref. 2405007-TR1), 2025; Process Design Criteria (Primero, 2024); The AtkinsRéalis Technical Note on tailings laboratory testing, "Geotechnical Laboratory Analysis
More news about: PMET Resources Inc.
Oct 20, 2025, 07:00 ET CITY OF LONDON INVESTMENT GROUP PLC ("City of London" or "the Group" or "the Company" or "CLIG") TRADING UPDATE FOR THE QUARTER TO 30 SEPTEMBER 2025
USA Net TR Index. The KIM Conservative Balanced Strategy is shown against the Blended 60% Bloomberg Government/Credit Bond Index/26% Russell 3000 Index/14% MSCI ACWI ex USA Net TR Index. The KIM Equities Strategy is shown against the Blended 65% Russell 3000 Index/35% MSCI ACWI ex USA Net TR Index.
More news about: City of London Investment Group PLC
Oct 16, 2025, 13:45 ET Smartphone-Based Relaxation Program Reduces Disability for Emergency Department Migraine Patients
Pediatrics at Cincinnati Children's Hospital. This research was supported by National Institutes of Health grants NCCIH K23 AT009706 and NIH NCATS UL1 TR001445. Dr. Minen has financial interests in the app and its RELAXaHEAD underlying intellectual property, which has been licensed to
More news about: NYU Langone Health System
Oct 16, 2025, 09:18 ET InCoax MoCA Access technology featured in "FWA Solution of the Year" at Network X Awards 2025
Sweden, Oct. 16, 2025 /PRNewswire/ -- Broadband Forum's Wireline-Wireless Convergence work area has published the TR-507 architecture specification for 5G mmWave FWA extension. Its multi-tenant 5G Fixed Wireless Access (FWA) solution for multi-dwelling units (MDUs)
More news about: InCoax Networks AB
Oct 16, 2025, 09:14 ET InCoax MoCA Access technology featured in "FWA Solution of the Year" at Network X Awards 2025
Sweden, Oct. 16, 2025 /PRNewswire/ -- Broadband Forum's Wireline-Wireless Convergence work area has published the TR-507 architecture specification for 5G mmWave FWA extension. Its multi-tenant 5G Fixed Wireless Access (FWA) solution for multi-dwelling units (MDUs)
More news about: InCoax Networks AB
Oct 14, 2025, 09:12 ET ERShares' XOVR ETF Opens the Door to Pre-IPO Stage Investing
XOVR was relaunched on August 30, 2024, when ERShares combined its proprietary Entrepreneur 30 Total Return Index (ER30TR) with selective private equity exposure, building a structure designed to capture growth opportunities across both the public and private markets.
More news about: ERShares
Oct 13, 2025, 08:28 ET Zeta Surgical® AI-powered TMS Navigation System Receives FDA 510(k) Clearance
maintain target alignment during patient movement. TMS is widely used in neuropsychiatry, particularly for treatment-resistant major depressive disorder (TR-MDD), which affects about one-third of patients with major depression worldwide. The FDA clearance covers use of the Zeta TMS Navigation
More news about: Zeta Surgical